ASTELLAS PHARMA UNSP.ADR Free Cash Flow Generation Index

Latest as of March 2025: 0.71x

ASTELLAS PHARMA UNSP.ADR free cash flow generation index. ASTELLAS PHARMA UNSP.ADR (YPHA) has a Free Cash Flow Generation Index of 0.71x as of March 2025. Free cash flow of €137.18 Billion represents 1% of operating cash flow (€194.51 Billion).

FCF Generation Index

0.71x
Free Cash Flow / Operating CF

Free Cash Flow

€137.18 Billion
EUR

Operating Cash Flow

€194.51 Billion
EUR

Capital Expenditures

€57.33 Billion
EUR

Free Cash Flow Generation Index of ASTELLAS PHARMA UNSP.ADR (2022–2025)

Free cash flow generation index of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. Historical FCF Generation Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. See ASTELLAS PHARMA UNSP.ADR (YPHA) flexibility index to measure the company's free cash flow as a share of total liabilities.

ASTELLAS PHARMA UNSP.ADR Free Cash Flow Generation Index by Year (2022–2025)

ASTELLAS PHARMA UNSP.ADR free cash flow generation index by year from 2022 to 2025. Year-by-year Free Cash Flow Generation Index for ASTELLAS PHARMA UNSP.ADR. For the full cash flow conversion analysis, see YPHA cash flow conversion.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 0.71x €137.18 Billion €194.51 Billion €57.33 Billion ▲ +35.2%
2024 0.52x €89.98 Billion €172.47 Billion €82.50 Billion ▼ -28.5%
2023 0.73x €239.23 Billion €327.77 Billion €88.54 Billion ▲ +3.8%
2022 0.70x €181.00 Billion €257.44 Billion €76.45 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).